Tag: Tempus
All the articles with the tag "Tempus".
Tempus AI Bull Case: Goldman Sachs Initiates Coverage with a Buy Rating
Published: at 04:45 AMGoldman Sachs initiates coverage on Tempus AI with a Buy rating and a $48 price target, driven by its proprietary data, AI-powered platform, and expansion into multiple disease areas, highlighting a positive outlook for the company.